About
LLLT (Low level laser therapy) is a painless, sterile, non-invasive, drug-free treatment which is used to treat a variety of pain syndromes, injuries, wounds, fractures, neurological conditions and pathologies. Laser therapy can be used any time a patient requests or needs a drugÂless procedure for the control of pain, when conventional therapies have been ineffective, or when the acceleration of healing from injuries is desired.
Biostimulation, including improved metabolism & increased cell metabolism
Improved blood circulation and vasodilatation
Analgesic effect
Anti-edematous effects Anti-inflammatory and
Stimulation of wound healing
Relieves acute and chronic pains
Increases the speed, quality and tensile strength of tissue repair
Increases blood supply
Stimulates the immune system
Stimulates nerve function
Develops collagen and muscle tissue
Helps generate new and healthy cells and tissue
Promotes faster wound healing and clot formation
Reduces inflammation
The ML830®
The MLA830 is a GaAlA Laser that has wavelength of 830 nm with a power output of 90 mw. At this wavelength and power the ML830® Laser has a penetration of approximately 5 cm or 2 inches.
It is not an accident that the Microlight Corporation of America chose & patented the 830nm technology for its ML830®. There are 30+ years of clinical studies that proved the 830nm range is the optimal wave-length. No other Low-Level Laser offers this superior amount of penetration of tissue!
GENERAL MOTORS DOUBLE BLIND STUDY
​As further background, General Motors had serious problems with Carpal Tunnel Syndrome among its workers. GM responded by conducting a 36-week double-blind study, using the ML830® to see if non-invasive conjunctive therapy would help. Among the 166 afflicted GM workers who entered the program, those treated with the ML830® laser showed significant improvement in grip strength and range of motion when compared to other GM workers who were treated with placebo lasers.
A prominent medical school in Houston conducted a similar double-blind study on CTS in 1998 that showed a 70% improvement after conjunctive therapy using the ML830® among those patients in the active group.
If you have any questions about our services, please contact us today at (817) 523-9590.